Focus: LSI Solutions is a medical device company specializing in minimally invasive surgical devices for cardiovascular applications, headquartered in Victor, NY and founded in 2018. The company focuses on innovative solutions for aortic valve disease and mitral regurgitation.
Profile data last refreshed 10h ago · AI intelligence enriched 3d ago
LSI Solutions is a speculative early-stage device play with focused innovation but limited transparency and maturity — best for risk-tolerant professionals seeking startup equity upside in cardiovascular devices.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for LSI Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from LSI Solutions's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo